Hematology

EXPERT discussion from a satellite symposium presented at the European Hematology Association (EHA) Virtual Congress 2021 focused on myelodysplastic syndrome (MDS), a heterogeneous group of myeloid malignancies characterised by ineffective haematopoiesis, progressive bone marrow failure, and increased risk of acute myeloid leukaemia evolution.

Multiple myeloma (MM) is an incurable disease and is the second most common haematologic malignancy in the world. Over the past decade…

Cutaneous T cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that develops in the T cells. Mycosis fungoides (MF) and Sézary…

Presentations on sickle cell disease (SCD) at the European Hematology Association (EHA) Virtual Congress 2021.

In this interview, two experts in the field of acute myeloid leukaemia (AML), Jean-Baptiste Micol, University of Paris-Saclay, France, and Thomas Cluzeau, University Hospital of Nice, France, share their views and debate the current landscape of real-world data in AML research and treatment.

This review provides a summary of the research presented by a panel of three experts at the virtual webcast symposium conference hosted by PeerVoice on 20th May 2021.

At the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), held virtually 3rd–5th…

Welcome to the latest issue of EMJ Hematology. We are excited to share with you an impressive collection of new and interesting research, alongside our independent review of the European Hematology Association (EHA) 2021 Virtual Congress with the fascinating updates from the event.